Sign In
Buy ABT
$87.02
+0.0600 (+0.0690%)
At Close: Jun 03, 2026
ABT DCF Analysis: Intrinsic Value $93 vs Price $88
07:04am, Tuesday, 02'nd Jun 2026
On June 02, 2026, we take a closer look at the DCF analysis for Abbott Laboratories (ABT). The stock has experienced notable price performance, with a year-to-d
3 Beaten-Down Stocks to Buy and Hold Forever
04:15am, Tuesday, 02'nd Jun 2026
Don't wait too long to buy the dip on these stocks.
Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock
10:56am, Monday, 01'st Jun 2026
ABT wins CE Mark for Libre Duo systems, the first dual glucose-ketone sensors, enabling real-time monitoring as European rollout begins later this year.
BSX vs. ABT: Which Medical Stock Has More Upside Potential?
10:16am, Friday, 29'th May 2026
Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
10:01am, Friday, 29'th May 2026
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
10:31am, Thursday, 28'th May 2026
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Wednesday, 27'th May 2026
Abbott (ABT) concluded the recent trading session at $85.68, signifying a -1.14% move from its prior day's close.
How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026
09:53am, Wednesday, 27'th May 2026
ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
09:00am, Wednesday, 27'th May 2026
First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to diabe
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
07:01am, Wednesday, 27'th May 2026
Cologuard® and Cologuard Plus® reaffirmed as preferred options for noninvasive colorectal cancer (CRC) screening in updated American Cancer Society guideline Abbott to offer only CRC screening portf
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
09:00am, Tuesday, 26'th May 2026
Data highlight how screening and diagnostics enable earlier detection, more precise treatment decisions, and improved patient outcomes from risk to remission New MRD data from the PARTNER study demons
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
09:15pm, Friday, 22'nd May 2026
When investors take a risk-off attitude, stocks with attractive, growing dividends are often their safe-haven option.
3 Stocks to Buy if You Think the Economy Is Heading for a Recession
02:30am, Thursday, 21'st May 2026
They have increased their payouts for a combined 171 years straight.
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
09:41am, Wednesday, 20'th May 2026
ABT's EPD unit posts 9% Q1 sales growth as biosimilars and emerging market demand support its long-term expansion plans.
Silver Economy Investing: Why the Healthcare Giants Are in Focus
04:01pm, Tuesday, 19'th May 2026
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
